Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17

Cellular and Molecular Immunology

Volumn 12, Issue 6, 2015, Pages 768-776

  Ren, Jing ^a   Nie, Yunzhong ^a   Lv, Mingming ^a   Shen, Sunan ^a   Tang, Ruijing ^a   Xu, Yujun ^a   Hou, Yayi ^a   Zhao, Shuli ^b   Wang, Tingting ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ADAM17; estradiol; MICA; MICB; tumor immune escape

Indexed keywords

ADAM PROTEIN; ADAM17 PROTEIN; CELL SURFACE RECEPTOR; ESTRADIOL; ESTROGEN; MESSENGER RNA; MICA PROTEIN; MICB PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; SECRETORY PROTEIN; UNCLASSIFIED DRUG; ADAM17 PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER CELL LINE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NON SMALL CELL LUNG CANCER; UPREGULATION; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOSURVEILLANCE; LUNG TUMOR; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR ESCAPE;

ADAM PROTEINS; ADAM17 PROTEIN; ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR ESCAPE;

EID: 84946049691     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.101     Document Type: Article

References (33)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
2. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2004; 45(Suppl 2): 3-9.
3. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers-A different disease. Nat Rev Cancer 2007; 7: 778-790.
4. Carey MA, Card JW, Voltz JW, Arbes SJ Jr, Germolec DR, Korach KS, et al. Its all about sex: gender, lung development and lung disease. Trends Endocrinol Metab 2007; 18: 308-313.
5. Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. Tissue distribution and quantitative analysis of estrogen receptor-Alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-Type and ERalpha-knockout mouse. Endocrinology 1997; 138: 4613-4621.
6. Raso MG, Behrens C, Herynk MH, Liu S, Prudkin L, Ozburn NC, et al. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res 2009; 15: 5359-5368.
7. Abe K, Miki Y, Ono K, Mori M, Kakinuma H, Kou Y, et al. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Hum Pathol 2010; 41: 190-198.
8. Hershberger PA, Stabile LP, Kanterewicz B, Rothstein ME, Gubish CT, Land S, et al. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. J Steroid Biochem Mol Biol 2009; 116: 102-109.
9. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005; 65: 1459-1470.
10. Mah V, Seligson DB, Li A, Márquez DC, Wistuba II, Elshimali Y, et al. Aromatase expression predicts survival in women with early-stage non-small cell lung cancer. Cancer Res 2007; 67: 10484-10490.
11. Zhao G, Zhao S, Wang T, Zhang S, Lu K, Yu L, et al. Estrogen receptor b signaling regulates the progression of Chinese non-small cell lung cancer. J Steroid Biochem Mol Biol 2011; 124: 47-57.
12. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781-790.
13. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 1999; 285: 727-729.
14. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR. Prevalent expression of the immunostimulatory MHC class I chainrelated molecule is counteracted by shedding in prostate cancer. J Clin Invest 2004; 114: 560-568.
15. Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, OReilly RJ, Dupont B, et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol 2003; 171: 6891-6899.
16. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419: 734-738.
17. Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005; 43: 1013-1020.
18. Basu S, Pioli PA, Conejo-Garcia J, Wira CR, Sentman CL. Estradiol regulates MICA expression in human endometrial cells. Clin Immunol 2008; 129: 325-332.
19. Zhao G, Nie Y, Lv M, He L, Wang T, Hou Y. ERb-mediated estradiol enhances epithelial mesenchymal transition of lung adenocarcinoma through increasing transcription of midkine. Mol Endocrinol 2012; 26: 1304-1315.
20. Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Scand J Immunol 2013; 78: 120-129.
21. Salih HR, Rammensee HG, Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002; 169: 4098-4102.
22. Waldhauer I, Goehlsdorf D, Gieseke F, Weinschenk T, Wittenbrink M, Ludwig A, et al. Tumor-Associated MICA is shed by ADAM proteases. Cancer Res 2008; 68: 6368-6376.
23. Waldhauer I, Steinle A. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res 2006; 66: 2520-2526.
24. Holdenrieder S, Stieber P, Peter WA, Nagel D, Steinle A, Salih HR. Soluble MICA in malignant diseases. Int J Cancer 2006; 118: 684-687.
25. Rebmann V, Schutt P, Brandhorst D, Opalka B, Moritz T, Nowrousian MR, et al. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Clin Immunol 2007; 123: 114-120.
26. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumour-Associated expression and recognition by tumour-derived cdT cells of MICA and MICB. Proc Natl Acad Sci USA 1999; 96: 6879-6884.
27. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, et al. MICA engagement by human T cells enhances their antigen-dependent effector function. Immunity 2001; 15: 83-93.
28. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8 abT cells by NKG2D via engagement by MIC induced on virus infected cells. Nat Immunol 2001; 2: 255-260.
29. Tieng V, Le Bouguénec C, du Merle L, Bertheau P, Desreumaux P, Janin A, et al. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci USA 2002; 99: 2977-2982.
30. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, et al. Role of the estogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 2003; 95: 353-361.
31. Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, et al. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines. J Immunol 2012; 188: 2136-2145.
32. Hao S, Li P, Zhao J, Hu Y, Hou Y. 17b-Estradiol suppresses cytotoxicity and proliferative capacity of murine splenic NK1.11 cells. Cell Mol Immunol 2008; 5: 357-364.
33. Alter G1, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15-22.